Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The Mil Familias Cohort Establishment involves enrolling 1000 Latino families with at least one member in the family having type 2 diabetes, including children and youth, and measuring the 5 determinants of human health: genetics, biology, behavior, psychology, and society/environment.
The vision of Mil Familias is to reduce the burden of cardio-metabolic disease among Latino families in Santa Barbara County and beyond. The aim is to establish an observational cohort of 1,000 Latino families, with at least one family member currently living with diabetes, in order to understand better the impact of the 5 determinants of human health (genetics, biology, behavior, psychology, and society/environment) in this population. Once the 1,000-family cohort is established, evidence-based intervention studies will be developed and implemented based on new knowledge, with collaborators from the healthcare, public policy, academic, pharmaceutical, medical device and technology industries. The strategy involves 4 coordinated and iterative components to achieve its mission:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adult Individuals with Type 2 diabetes | Individuals ≥18 years of Hispanic/Latino heritage with an established diagnosis of type 2 diabetes | ||
| Adult Family member | Adult family members, ≥18 years, of the individual with type 2 diabetes | ||
| Child family member with diabetes | Child, ≥7 years but <18 years, family member with diabetes | ||
| Child family member without diabetes | Child, ≥7 years but <18 years, family member without diabetes |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Success (evaluated by Yes/No format) recruiting and establishing an observational cohort of 1,000 Latino families with at least one family member living with type 2 diabetes by deploying the methods proven feasible by Mil Familias Operational Pilot. | The Mil Familias Cohort Establishment will expand upon the Mil Familias Operational Pilot cohort and infrastructure to collect and store the up to 100 proposed variables across the 5 determinants of human health to support long-term Mil Familias implementation. The variables pertaining to each participant will be collected and stored at the initial visit and then annually for up to 3 years. Socio-demographic characteristics of the cohort will be described at enrollment by type 2 diabetes status, including age, gender, self-identified race/ethnicity, number of people in household, education, insurance, income, occupation, HbA1c, and country of birth. | 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Socio-demographics assessed by questionnaire. | Socio-demographics measured by questionnaire - including age, gender, self-identified race/ethnicity, contact information, number in household, income, education, marital status, occupation, caring for elder, night shifts, insurance status, insurance type and payer, influenza immunization status, immigration status, alcohol & tobacco use, birth place,and duration of time in the United States (<5 years, 5-9 years, 10-14 years, 15-19 years, 20-24 years, ≥25 years). |
| Measure | Description | Time Frame |
|---|---|---|
| Physical activity measured by two wearable physical activity monitors for 1 week | Participants wear an ActiGraph and Fitbit activity monitors simultaneously for 1 week, complete an activity log, and answer a user experience questionnaire. | On-going activity encounter up to twice in 1 year |
Inclusion Criteria:
Males or females ≥ 7 years of age at enrollment.
Self-reported Latino heritage.
Co-resides with immediate family member (as defined above) OR self with established diagnosis of Type 2 Diabetes for at least one year prior to enrollment date.
Signed and dated written informed consent by the date of enrollment.
Based on the research staff's judgment, subject or subject's representative must have a good understanding, ability, and willingness to adhere to the protocol, including performance of self-monitored data collection during the wearable device portion.
-
Exclusion Criteria:
Not provided
Not provided
Not provided
Up to 1,200 families may be screened and enrolled with the prediction of 20% screen-fail or dropout and 1,000 families enrolled in the study. A "family" will be followed as one unit but is estimated to include on average 3 to 5 individuals based on the findings from the Operational Pilot. Up to 6,000 individuals may be enrolled in this study.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Kerr, MBChB DM FRCP | Sansum Diabetes Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sansum Diabetes Research Institute | Santa Barbara | California | 93105 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35771029 | Derived | Kerr D, Abbasi M, Bevier W, Glantz N, Larez A, Sabharwal A. Patterns of Timing and Intensity of Physical Activity and HbA1c Levels in Hispanic/Latino Adults With or at Risk of Type 2 Diabetes. J Diabetes Sci Technol. 2024 Jan;18(1):106-112. doi: 10.1177/19322968221105531. Epub 2022 Jun 30. | |
| 31906923 | Derived |
Not provided
Not provided
All individual participant data (IPD) that underlie results in publications.
Data will be made available after the primary publication of each analysis.
Data Sharing Agreements will be formulated by a committee of study investigators and community and industry partners.
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Serum, plasma, buffy coat (white cells), saliva, feces, urine, cheek cells
| Introductory interview/ demographics/ contacts and annually up to 3 years |
| Number of healthcare visits and the difficulty in traveling to the healthcare provider assessed by questionnaire | Number of visits to a healthcare provider in the last year and difficulty in traveling to a healthcare provider measured by interview questionnaire | Introductory interview/ demographics/ contacts and annually up to 3 years |
| Questions regarding personal opinions regarding the burden of diabetes on Latinos measured by specific questions | Personal opinion regarding type 2 diabetes burden on Latinos measured by 3 questions - why is diabetes common in Latinos, what can be done to prevent diabetes in Latinos, and what things make it difficult to get help with diabetes when it is needed? | Introductory interview/ demographics/ contacts and annually up to 3 years |
| Total daily tortilla consumption | The number of flour and/or corn tortillas consumed daily for the past 30 days is estimated | Introductory interview/ demographics/ contacts and annually up to 3 years |
| Daily sugary drink consumption | Daily sugary drink consumption is measured by the 2 questions in the Sugar Sweetened Beverages module of the Behavioral Risk Factor Surveillance System Questionnaire from the Centers for Disease Control. | Introductory interview/ demographics/ contacts and annually up to 3 years |
| Number of times per week eating meals prepared away from home | NHANES 2017-2018 question asked - During the past 7 days, how many meals did you get that were prepared away from home in places such as restaurants, fast food places, food stands, grocery stores, or from vending machines? | Introductory interview/ demographics/ contacts and annually up to 3 years |
| Laboratory blood draw for evaluation of C-Peptide related to diabetes | C-Peptide, ng/mL, will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Laboratory blood draw for evaluation of C-Reactive protein related to diabetes | C-Reactive protein, mg/L, will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Laboratory blood draw for evaluation of Complete Blood Count | Complete Blood Count will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Laboratory blood draw for evaluation of Comprehensive Metabolic Panel | Comprehensive Metabolic Panel will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Laboratory blood draw for evaluation of Glutamic Acid Decarboxylase (GAD) antibodies related to diabetes | Glutamic Acid Decarboxylase (GAD) antibodies, U/mL, will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Laboratory blood draw for evaluation of HbA1c related to diabetes | HbA1c % will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Laboratory blood draw for evaluation of Insulin autoantibody related to diabetes | Insulin autoantibody, U/mL, will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Laboratory blood draw for evaluation of Islet antigen 2 (IA-2) antibody related to diabetes | Islet antigen 2 (IA-2) antibody, U/mL, will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Laboratory blood draw for evaluation of lipids | Lipids will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Laboratory blood draw for evaluation of Insulin | Insulin, milliunits/L, will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Laboratory blood draw for evaluation of thyroid function | Thyroid function will measured in a laboratory blood draw sample. | Laboratory encounter and annually up to 3 years |
| Microalbumin measured in a urine sample | Urine sample collected for measuring microalbumin mg/L | Laboratory encounter and annually up to 3 years |
| Creatinine measured in a urine sample | Urine sample collected for measuring creatinine | Laboratory encounter and annually up to 3 years |
| Microalbumin/creatinine ratio measured in a urine sample | Urine sample collected for measuring the microalbumin/creatinine ratio | Laboratory encounter and annually up to 3 years |
| Cheek cells and saliva for genomic analysis | Cheek epithelial cells from a swab and saliva samples will be collected for genetic analysis | Laboratory encounter and annually up to 3 years |
| Stool samples for microbiome analysis | Stool/fecal samples will be collected for microbiome analysis | Laboratory encounter and annually up to 3 years |
| Height measured by Physical exam | Height measured in centimeters or inches by physical exam | Physical exam encounter and annually up to 3 years |
| Weight measured by Physical exam | Weight measured in kilograms or pounds by physical exam | Physical exam encounter and annually up to 3 years |
| Waist circumference measured by Physical exam | Waist circumference measured in centimeters or inches by physical exam | Physical exam encounter and annually up to 3 years |
| Blood pressure measured by Physical exam | Blood pressure, systolic and diastolic, measured in mmHg by physical exam | Physical exam encounter and annually up to 3 years |
| Temperature measured by Physical exam | Temperature measured in degrees by physical exam | Physical exam encounter and annually up to 3 years |
| Heart rate measured by Physical exam | Heart rate measured in beats per minute by physical exam | Physical exam encounter and annually up to 3 years |
| Foot examination evaluated by Questions and Physical exam | Foot examination with yes or no questions and by physical exam | Physical exam encounter and annually up to 3 years |
| Neuropathy Questions during Physical exam | Questions about neuropathy | Physical exam encounter and annually up to 3 years |
| Retinopathy questions during Physical exam | Questions about retinopathy | Physical exam encounter and annually up to 3 years |
| Dental exam Questions during Physical exam | Questions about dental exams | Physical exam encounter and annually up to 3 years |
| Eye exam Questions during Physical exam | Questions about eye exams | Physical exam encounter and annually up to 3 years |
| Medical history, family medical history, and medication status and history assessed by interview | Medical history including date of diabetes diagnosis, family medical history, and current medications verified by visual inspection and medication history assessed by interview questionnaire | Physical exam encounter and annually up to 3 years |
| Menopausal status, pregnancy status, and gestational diabetes history for women determined by interview | Menopausal status, pregnancy status (number of live births, number of stillbirths, birthweights of live births, and any diagnosis of type 1 diabetes), and gestational diabetes history for female participants will be determined by interview | Physical exam encounter and annually up to 3 years |
| Determination of diabetes related foot disease | Questionnaire for determination of diabetes related foot disease (Q-DFD) | Questionnaires encounter and annually up to 3 years |
| Acculturation measured by the Brief Acculturation Scale for Hispanics (BASH) | BASH is a participant reported questionnaire to measure acculturation. Responses are scored as 1 = only Spanish, 2 = Spanish more than English, 3 = Spanish and English equally, 4 = English more than Spanish, and 5 = only English. Items are summed and divided by the number of items. Low acculturation is less than or equal to 3.0, and high acculturation is greater than or equal to 3.0. | Questionnaire encounter and annually up to 3 years |
| Quality of life measured by the Short Form Health Survey (SF-12) | The SF-12 is a participant reported questionnaire to measure quality of life | Questionnaires encounter and annually up to 3 years |
| Depression measured by the Patient Health Questionnaire-9 | The Patient Health Questionnaire (PHQ)-9 is the Major Depressive Disorder (MDD) module of the full PHQ | Questionnaires encounter and annually up to 3 years |
| Perceived Ethnic Discrimination measured by the Brief Perceived Ethnic Discrimination Questionnaire - Community version (PEDQ-CV) | PEDQ-CV is a participant reported questionnaire to measure perceived ethnic discrimination | Questionnaires encounter and annually up to 3 years |
| Adverse Childhood Experiences (ACE) quantified by ACE questionnaire | Adverse Childhood Experiences (ACEs) refers to a range of events that a child can experience, which lead to stress and can result in trauma and chronic stress responses. An ACE score will be quantified by a specific ACE questionnaire. | Questionnaires encounter and annually up to 3 years |
| Spirituality measured by a Spiritual Well Being Scale | FACIT" (Functional Assessment of Chronic Illness Therapy) Sp-12 is a questionnaire for measuring spiritual well being. Questions are scored from 0 = Not at all to 4 = Very much. Sub-scales are created for meaning, peace, and faith with score ranges of 0 - 16. Adding these 3 scores gives a total score and the range is 0 - 48 with low scores indicating low spiritual well being and high scores indicating higher spiritual well being. | Questionnaires encounter and annually up to 3 years |
| Risk Perception Survey For Developing Diabetes (RPS-DD) | Diabetes risk perception will be measured by the Risk Perception Survey For Developing Diabetes (RPS-DD) | Questionnaires encounter and annually up to 3 years |
| Sleep quality measured by the Oviedo Sleep Questionnaire (OSQ) | The OSQ is a participant reported questionnaire to measure sleep quality | Questionnaires encounter and annually up to 3 years |
| Stress measured by the 4 item Perceived Stress Scale (PSS) | PSS is a participant reported questionnaire to measure stress. The scale ranges from 0 = never to 4 = very often. The final score ranges from 0 - 16, with higher scores indicating more stress. | Questionnaires encounter and annually up to 3 years |
| Drug abuse measured by the Drug Abuse Screening Test (DAST) - 20 | The purpose of the DAST-20 is to provide a brief, simple, practical, but valid method for identifying individuals who are abusing psychoactive drugs; and to yield a quantitative index score of the degree of problems related to drug use and misuse | Questionnaires encounter and annually up to 3 years |
| Diabetes management measured by the Diabetes Symptom Self-Care Inventory | Ability to manage diabetes self-care assessed by the Diabetes Symptom Self-Care Inventory (DSSCI) | Questionnaires encounter and annually up to 3 years |
| Family diabetes management measured by questionnaire | Family diabetes Self-Efficacy for management of diabetes measured by questionnaire (FSE) | Questionnaires encounter and annually up to 3 years |
| Foot self care confidence measured by questionnaire | Foot Care Confidence Scale (FCCS) is an instrument designed to measure the confidence (self-efficacy) of individuals with type 2 diabetes to perform foot self care | Questionnaires encounter and annually up to 3 years |
| Health literacy measured by the Short Assessment of Health Literacy (SAHL) | SAHL is a participant reported questionnaire to measure health literacy | Questionnaires encounter and annually up to 3 years |
| Measurement of health numeracy | Newest Vital Sign (NVS) is a tool to assess health literacy and numeracy in English and Spanish | Questionnaires encounter and annually up to 3 years |
| Trust in physician measured by the Trust in Physician (TPS) questionnaire | The TPS is a questionnaire and scale to determine trust in the physician | Questionnaires encounter and annually up to 3 years |
| Social needs screening assessed by the Health Leads Screening toolkit | The Health Leads Screening tookit (Boston, MA) will be used to determine social needs - housing instability, childcare, utility needs, financial resource strain, transportation, and exposure to violence. | Questionnaires encounter and annually up to 3 years |
| Food security assessed by U.S. Household Food Security Survey Module: Six-item short form | Food security or insecurity assessed by a six-item short form developed by the Economic Research Service, United States Department of Agriculture (USDA), September 2012 | Questionnaires encounter and annually up to 3 years |
| Functional support measured by the SSQ6 | Social Support Questionnaire - Short Form (SSQ6) measures functional social support | Questionnaires encounter and annually up to 3 years |
| Support structure measured by Medical Outcomes Study Social Support Survey (mMOS-SS) | The eight-item modified Medical Outcomes Study Social Support Survey (mMOS-SS) measures support structure by counting the number of people supporting and satisfaction with that support | Questionnaires encounter and annually up to 3 years |
| National survey of children's health (NSCH) for all children and youth | The NSCH, a validated survey of children's health and translated into Spanish, will assess health of children and youth | Questionnaires encounter and annually up to 3 years |
| Morales J, Glantz N, Larez A, Bevier W, Conneely M, Fan L, Reed B, Alatorre C, Paczkowski R, Ahmed T, Mackenzie A, Duncan I, Kerr D. Understanding the impact of five major determinants of health (genetics, biology, behavior, psychology, society/environment) on type 2 diabetes in U.S. Hispanic/Latino families: Mil Familias - a cohort study. BMC Endocr Disord. 2020 Jan 6;20(1):4. doi: 10.1186/s12902-019-0483-z. |
| D004700 | Endocrine System Diseases |